Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 USD | +1.42% |
|
-2.73% | +0.35% |
05-15 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
05-15 | Aytu BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.35% | 15.87M | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Aytu Biopharma, Inc. Announces Resignation of Steven J. Boyd as a Members of the Board of Directors